Cardiorenalmetabolic

Latest News

Hamlet Gasoyan, PhD
Improve Antiobesity Medication Adherence to Improve Results: Hamlet Gasoyan, PhD

June 26th 2025

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says Hamlet Gasoyan, PhD, Cleveland Clinic.

Cardiologist listening to patient's heart | Image credit: Space_Cat – stock.adobe.com
40% of Patients With Heart Failure Don’t See Cardiologist Annually, Increasing Risk of Death

June 19th 2025

Hamlet Gasoyan, PhD
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD

June 19th 2025

CBD oils and hemp leaves | Image credit: Irina_Evva – stock.adobe.com
CBD-Based Drug Shows No Heart Safety Risks in Patients With CVD or Risk Factors

May 23rd 2025

AJMC
Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

May 16th 2025

More News

Doctor and patient discussing treatment plan | Image credit: Halfpoint – stock.adobe.com
July 5th 2024

GLP-1 Agonists May Reduce Cancer Risk for Patients With Diabetes

Hayden E. Klein
Among patients with type 2 diabetes, glucagon-like peptide 1 (GLP-1) receptor agonists reduced their risk of obesity-related cancers more than insulin did.
counting calories | Image Credit: Andrii Symonenko-stock.adobe.com
June 27th 2024

T1D Management: Carbohydrate Counting With Technology

Kimberly Rath, PharmD
A new study highlights the potential of technology to aid in type 1 diabetes (T1D) management by balancing minimal user input with significant data output to improve user engagement and time in range.
Ian Neeland, MD
June 21st 2024

Obesity Management in 2024: A Look at the CINEMA Program’s Growth and Impact

Hayden E. Klein
The University Hospitals CINEMA program aims to address issues and narrow gaps in obesity management, with a focus on meeting patients where they are and providing them tools for success, says Ian Neeland, MD.
Robert Lustig, MD, MSL
June 21st 2024

Dr Robert Lustig on Pediatric Metabolic Health: “Sugar Is the Alcohol of the Child”

Hayden E. Klein
Robert Lustig, MD, MSL, explains how the US health care industry needs to shift from measuring body mass index and obesity to measuring cardiometabolic health, which affects 93% of Americans, including children.
Ozempic | Image credit: mbruxelle – stock.adobe.com
June 20th 2024

WHO Issues Warning for Fake Semaglutide

Hayden E. Klein
Taking falsified semaglutide (Ozempic; Novo Nordisk) can lead to ineffective treatment due to incorrect dosing, contamination, and the use of unknown ingredients, the World Health Organization (WHO) is warning.
older person with T1D | Image Credit: dorde-stock.adobe.com
June 19th 2024

More People With T1D Are Living Into Old Age

Jared Kaltwasser
A new prevalence study shows more people are living beyond age 65 with type 1 diabetes (T1D).
Age, Insurance Play Major Roles in CGM Use, Says Dr Chase Hendrickson
June 18th 2024

Age, Insurance Play Major Roles in CGM Use, Says Dr Chase Hendrickson

Hayden E. Klein
Patients with diabetes who have private insurance are more likely to be prescribed a continuous glucose monitor (CGM) compared with those with government insurance, says Chase Hendrickson, MD, MPH, Vanderbilt University Medical Center.
Blood vessel | Image credit: Dr_Microbe – stock.adobe.com
June 17th 2024

STRONG-HF Data Suggest Bio-ADM Enhances Heart Failure Prognostic Value

Hayden E. Klein
Patients with the highest biologically active adrenomedullin (bio-ADM) levels at baseline were 114% more likely to die from any cause or be readmitted to the hospital for heart failure within 6 months compared with patients with the lowest levels.
blood sugar control concept | Image Credit: Phruetthiphong-stock.adobe.com
June 16th 2024

AYA With T1D Have Suboptimal Glucose Control

AJMC Contributor
Notably, adolescents and young adults (AYA) living with type 1 diabetes (T1D) who reported more comfort with self-management tended to have worse glycemic control.
Kathryn Lindley, MD, FACC
June 15th 2024

Dr Kathryn Lindley Addresses Barriers to Women’s Heart Disease Diagnosis

Hayden E. Klein
It’s important for clinicians to listen to patients and know how heart disease may affect women differently than men, said Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Older woman smelling flowers | Image credit: Halfpoint – stock.adobe.com
June 14th 2024

Loss of Smell May Predict Heart Failure Risk

Hayden E. Klein
Adults aged 70 and older were significantly more likely to develop congestive heart failure if they also experienced olfactory impairment.
FDA | Image credit: Araki Illustrations – stock.adobe.com
June 13th 2024

FDA Approves Dapagliflozin for Children With Type 2 Diabetes

Hayden E. Klein
Children aged 10 years and older with type 2 diabetes can now improve their glycemic control with a drug previously only approved for adults.
T1D icon | Image Credit: MQ-Illustrations-stock.adobe.com
June 12th 2024

Gender May Affect Whether, Why Patients With T1D Exercise

Jared Kaltwasser
Men are less likely than women to desire community when exercising, the authors found.
Jeff Levin-Scherz, MD, MBA
June 11th 2024

Dr Jeff Levin-Scherz Addresses Gaps in Obesity Care and Funding Challenges

Hayden E. Klein
Jeff Levin-Scherz, MD, MBA, population health leader at WTW, explains that obesity care in the US is inconsistent and costly, with significant gaps across Medicare, Medicaid, and employer-based insurance.
<12345>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo